GB1497409A - Method of therapeutically treating metastatic cancers - Google Patents

Method of therapeutically treating metastatic cancers

Info

Publication number
GB1497409A
GB1497409A GB17502/77A GB1750277A GB1497409A GB 1497409 A GB1497409 A GB 1497409A GB 17502/77 A GB17502/77 A GB 17502/77A GB 1750277 A GB1750277 A GB 1750277A GB 1497409 A GB1497409 A GB 1497409A
Authority
GB
United Kingdom
Prior art keywords
site
produce
residue
available hydroxyl
residues
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB17502/77A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alseres Pharmaceuticals Inc
Original Assignee
Strategic Medial Research Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US05/424,786 external-priority patent/US3939146A/en
Application filed by Strategic Medial Research Corp filed Critical Strategic Medial Research Corp
Publication of GB1497409A publication Critical patent/GB1497409A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H9/00—Compounds containing a hetero ring sharing at least two hetero atoms with a saccharide radical
    • C07H9/02—Compounds containing a hetero ring sharing at least two hetero atoms with a saccharide radical the hetero ring containing only oxygen as ring hetero atoms
    • C07H9/04—Cyclic acetals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Biotechnology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
GB17502/77A 1973-12-14 1974-12-13 Method of therapeutically treating metastatic cancers Expired GB1497409A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US05/424,786 US3939146A (en) 1973-03-01 1973-12-14 Novel ethereal monosubstitutions of monosaccharide derivatives
AU44869/79A AU533108B2 (en) 1973-12-14 1979-03-07 Etherfied monosaccharides

Publications (1)

Publication Number Publication Date
GB1497409A true GB1497409A (en) 1978-01-12

Family

ID=25626947

Family Applications (4)

Application Number Title Priority Date Filing Date
GB17501/77A Expired GB1497408A (en) 1973-12-14 1974-12-13 Method for increasing the life span of tissue culture cells
GB17500/77A Expired GB1497407A (en) 1973-12-14 1974-12-13 Therapeutic compositions
GB53972/74A Expired GB1497406A (en) 1973-12-14 1974-12-13 Ethereal monosubstitutions of monosaccharide derivatives
GB17502/77A Expired GB1497409A (en) 1973-12-14 1974-12-13 Method of therapeutically treating metastatic cancers

Family Applications Before (3)

Application Number Title Priority Date Filing Date
GB17501/77A Expired GB1497408A (en) 1973-12-14 1974-12-13 Method for increasing the life span of tissue culture cells
GB17500/77A Expired GB1497407A (en) 1973-12-14 1974-12-13 Therapeutic compositions
GB53972/74A Expired GB1497406A (en) 1973-12-14 1974-12-13 Ethereal monosubstitutions of monosaccharide derivatives

Country Status (12)

Country Link
JP (1) JPS5619877B2 (ja)
AT (1) AT352145B (ja)
AU (1) AU533108B2 (ja)
BE (1) BE823313A (ja)
CA (1) CA1030960A (ja)
CH (1) CH606073A5 (ja)
DD (1) DD116029A5 (ja)
DE (1) DE2455026A1 (ja)
FR (1) FR2254348B2 (ja)
GB (4) GB1497408A (ja)
IN (2) IN141230B (ja)
SE (1) SE7415662L (ja)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3812181A1 (de) * 1988-04-13 1989-10-26 Werner E G Prof Dr Mueller Arzneimittel, enthaltend natuerliche und/oder chemisch modifizierte mono- oder polysaccharide und deren verwendung

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1227276A (en) * 1975-03-28 1977-09-29 Strategic Medical Res Corp Ethers of monosaccarides
US4996195A (en) * 1989-01-09 1991-02-26 Greenwich Pharmaceuticals Inc. Derivatives of α,D-glucofuranose or α,D-allofuranose and intermediates for preparing these derivatives
US5010058A (en) * 1989-06-22 1991-04-23 501 Greenwich Pharmaceuticals Incorporated 3,5,6-substituted derivatives of 1,2-O-isopropylidene-α,D-glucofuranose and intermediates for preparing these derivatives
US20020165168A1 (en) * 1995-12-16 2002-11-07 Joachim Bunger Use of sugar derivatives as antimicrobial, antimycotic and/or antiviral active substances

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1793336C3 (de) * 1967-09-11 1974-10-03 Ciba-Geigy Ag, Basel (Schweiz) D-Glucofuranoside, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Präparate
JPS5118195B2 (ja) * 1972-06-19 1976-06-08
US3939145A (en) * 1973-03-01 1976-02-17 Strategic Medical Research Corporation Novel ethereally monosubstituted monosaccharides

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3812181A1 (de) * 1988-04-13 1989-10-26 Werner E G Prof Dr Mueller Arzneimittel, enthaltend natuerliche und/oder chemisch modifizierte mono- oder polysaccharide und deren verwendung

Also Published As

Publication number Publication date
GB1497407A (en) 1978-01-12
AU7611374A (en) 1976-06-10
GB1497408A (en) 1978-01-12
CA1030960A (en) 1978-05-09
IN141230B (ja) 1977-02-05
BE823313A (fr) 1975-06-13
JPS5093909A (ja) 1975-07-26
SE7415662L (ja) 1975-06-16
JPS5619877B2 (ja) 1981-05-09
AU533108B2 (en) 1983-11-03
FR2254348B2 (ja) 1980-03-21
FR2254348A2 (ja) 1975-07-11
AU4486979A (en) 1979-07-05
DD116029A5 (ja) 1975-11-05
CH606073A5 (ja) 1978-10-13
DE2455026A1 (de) 1975-07-03
GB1497406A (en) 1978-01-12
DE2455026C2 (ja) 1988-02-25
IN144240B (ja) 1978-04-15
ATA989874A (de) 1979-02-15
AT352145B (de) 1979-09-10

Similar Documents

Publication Publication Date Title
KR880000370A (ko) 치환된 페닐화합물
ID21654A (id) Proses derivatisasi selektif taksana
KR950032262A (ko) 프로피오페논 유도체 및 이의 제조방법
GB1497409A (en) Method of therapeutically treating metastatic cancers
ES398029A1 (es) Un procedimiento para la produccion de una sal farmaceuti- camente aceptable de una bis-cromona.
KR900011784A (ko) α, D-글루코푸라노오스 또는 α,D-알로푸라노오스 유도체와 중간체 및 그의 제조방법
DE69103087D1 (de) N-substituierte Trifluormethylphenyltetrahydropyridine, Verfahren zur Herstellung, Zwischenprodukte, sowie Arzneimittel, die solche enthalten.
ES420628A1 (es) Procedimiento para la preparacion de n-(furiu-metil)-morfi-nanos.
KR910700230A (ko) 신규 히드록실아민 유도체
KR860008962A (ko) 테르펜 유도체의 제조방법
IT1201937B (it) Glucosidi antraciclinonici
USRE30379E (en) Ethereal monosubstitutions of monosaccharide derivatives
KR910004557A (ko) 2,4,6-치환 페놀 유도체
KR890002128A (ko) 실비빈의 가용성 유도체, 그것의 제조방법 및 그것을 함유하는 제약학적 조성물
USRE33000E (en) Therapeutic composition and method of treating viruses
ES8301631A1 (es) Un metodo para la preparacion de una formulacion farmaceutica de un antibiotico glicosidico o similar.
KR940013500A (ko) 수생 종의 그람-양성 질환 치료방법
KR880001690A (ko) 바이러스 복제 및 바이러스 병의 억제 방법
Bonner et al. A detailed investigation of the acid-catalysed formation of acetals from acetone and D-glucitol
KR910000777A (ko) 정균 활성을 갖는 안트라사이클린 유도체
JPS6434913A (en) Antitumor agent
NISHIKAWA et al. Chemical and Biochemical Studies on Carbohydrate Esters. XI. Antitumor Effects of Fatty Acid Monoesters of D-Glucose
KR920011486A (ko) 항종양제
KR880013963A (ko) 글루코피라노즈 유도체
KR890001528A (ko) 성인 t-세포 백혈병/임파종의 억제를 위한 아바론, 아바롤 및 그 유도체의 용도

Legal Events

Date Code Title Description
PS Patent sealed [section 19, patents act 1949]
PCNP Patent ceased through non-payment of renewal fee